ID   TOP2A_MOUSE             Reviewed;        1528 AA.
AC   Q01320; E9PX08;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 2.
DT   18-JUN-2025, entry version 223.
DE   RecName: Full=DNA topoisomerase 2-alpha;
DE            EC=5.6.2.2 {ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:1331984};
DE   AltName: Full=DNA topoisomerase II, alpha isozyme;
GN   Name=Top2a; Synonyms=Top-2, Top2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=1331984; DOI=10.1093/nar/20.20.5297;
RA   Adachi N., Miyaike M., Ikeda H., Kikuchi A.;
RT   "Characterization of cDNA encoding the mouse DNA topoisomerase II that can
RT   complement the budding yeast top2 mutation.";
RL   Nucleic Acids Res. 20:5297-5303(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1254-1528.
RC   TISSUE=Lymphoma;
RX   PubMed=8261398;
RA   McPherson J., Brown G.A., Goldenberg G.J.;
RT   "Characterization of a DNA topoisomerase IIalpha gene rearrangement in
RT   adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA
RT   transcript encoding topoisomerase IIalpha and the retinoic acid receptor
RT   alpha locus.";
RL   Cancer Res. 53:5885-5889(1993).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1211; THR-1245; THR-1323;
RP   SER-1328; SER-1333; THR-1350; SER-1373; SER-1388 AND SER-1521, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1418 AND LYS-1438, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [6]
RP   FUNCTION.
RX   PubMed=24321095; DOI=10.1016/j.bbrc.2013.11.116;
RA   Ogawa Y., Kawano Y., Yamazaki Y., Onishi Y.;
RT   "Shikonin shortens the circadian period: possible involvement of Top2
RT   inhibition.";
RL   Biochem. Biophys. Res. Commun. 443:339-343(2014).
RN   [7]
RP   INTERACTION WITH GCNA.
RX   PubMed=31839538; DOI=10.1016/j.devcel.2019.11.006;
RA   Dokshin G.A., Davis G.M., Sawle A.D., Eldridge M.D., Nicholls P.K.,
RA   Gourley T.E., Romer K.A., Molesworth L.W., Tatnell H.R., Ozturk A.R.,
RA   de Rooij D.G., Hannon G.J., Page D.C., Mello C.C., Carmell M.A.;
RT   "GCNA Interacts with Spartan and Topoisomerase II to Regulate Genome
RT   Stability.";
RL   Dev. Cell 52:53-68(2020).
CC   -!- FUNCTION: Key decatenating enzyme that alters DNA topology by binding
CC       to two double-stranded DNA molecules, generating a double-stranded
CC       break in one of the strands, passing the intact strand through the
CC       broken strand, and religating the broken strand (PubMed:1331984). May
CC       play a role in regulating the period length of BMAL1 transcriptional
CC       oscillation (PubMed:24321095). {ECO:0000269|PubMed:1331984,
CC       ECO:0000269|PubMed:24321095}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-dependent breakage, passage and rejoining of double-
CC         stranded DNA.; EC=5.6.2.2; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00995, ECO:0000269|PubMed:1331984};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00995};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00995};
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU00995};
CC       Note=Binds two Mg(2+) per subunit. The magnesium ions form salt bridges
CC       with both the protein and the DNA. Can also accept other divalent metal
CC       cations, such as Mn(2+) or Ca(2+). {ECO:0000255|PROSITE-
CC       ProRule:PRU00995};
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with COPS5 (By
CC       similarity). Interacts with RECQL5; this stimulates DNA decatenation
CC       (By similarity). Interacts with SETMAR; stimulates the topoisomerase
CC       activity (By similarity). Interacts with DHX9; this interaction occurs
CC       in a E2 enzyme UBE2I- and RNA-dependent manner, negatively regulates
CC       DHX9-mediated double-stranded DNA and RNA duplex helicase activity and
CC       stimulates TOP2A-mediated supercoiled DNA relaxation activity (By
CC       similarity). Interacts with HNRNPU (via C-terminus); this interaction
CC       protects the topoisomerase TOP2A from degradation and positively
CC       regulates the relaxation of supercoiled DNA in a RNA-dependent manner
CC       (By similarity). Interacts with MCM3AP (By similarity). Interacts with
CC       ERCC6 (By similarity). Interacts with PLSCR1 (By similarity). Interacts
CC       with GCNA; this interaction allows the resolution of topoisomerase II
CC       (TOP2A) DNA-protein cross-links (PubMed:31839538). Interacts with
CC       POL1RA/RPA1 (via dock II) and UBTF in the context of Pol I complex; may
CC       assist Pol I transcription initiation by releasing supercoils occurring
CC       during DNA unwinding. Interacts with TPRN; TPRN interacts with a number
CC       of DNA damage response proteins, is recruited to sites of DNA damage
CC       and may play a role in DNA damage repair (By similarity).
CC       {ECO:0000250|UniProtKB:P11388, ECO:0000250|UniProtKB:P41516,
CC       ECO:0000269|PubMed:31839538}.
CC   -!- INTERACTION:
CC       Q01320; Q3TKT4: Smarca4; NbExp=3; IntAct=EBI-642809, EBI-1210244;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P11388}.
CC       Nucleus, nucleoplasm {ECO:0000250|UniProtKB:P11388}. Nucleus
CC       {ECO:0000250|UniProtKB:P11388}. Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:P11388}.
CC   -!- PTM: Phosphorylation has no effect on catalytic activity (By
CC       similarity). However, phosphorylation at Ser-1105 by CSNK1D/CK1
CC       promotes DNA cleavable complex formation (By similarity).
CC       {ECO:0000250|UniProtKB:P11388}.
CC   -!- MISCELLANEOUS: Eukaryotic topoisomerase I and II can relax both
CC       negative and positive supercoils, whereas prokaryotic enzymes relax
CC       only negative supercoils.
CC   -!- SIMILARITY: Belongs to the type II topoisomerase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D12513; BAA02076.1; -; mRNA.
DR   EMBL; AL591067; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; U01915; AAC52135.1; -; mRNA.
DR   CCDS; CCDS25370.1; -.
DR   PIR; JS0703; JS0703.
DR   RefSeq; NP_035753.2; NM_011623.2.
DR   RefSeq; XP_006533216.1; XM_006533153.4.
DR   AlphaFoldDB; Q01320; -.
DR   SMR; Q01320; -.
DR   BioGRID; 204276; 29.
DR   CORUM; Q01320; -.
DR   DIP; DIP-40621N; -.
DR   FunCoup; Q01320; 1609.
DR   IntAct; Q01320; 22.
DR   MINT; Q01320; -.
DR   STRING; 10090.ENSMUSP00000068896; -.
DR   ChEMBL; CHEMBL3586; -.
DR   GlyGen; Q01320; 3 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q01320; -.
DR   PhosphoSitePlus; Q01320; -.
DR   SwissPalm; Q01320; -.
DR   jPOST; Q01320; -.
DR   PaxDb; 10090-ENSMUSP00000068896; -.
DR   PeptideAtlas; Q01320; -.
DR   ProteomicsDB; 260721; -.
DR   Pumba; Q01320; -.
DR   Antibodypedia; 1583; 1563 antibodies from 45 providers.
DR   DNASU; 21973; -.
DR   Ensembl; ENSMUST00000068031.8; ENSMUSP00000068896.8; ENSMUSG00000020914.18.
DR   GeneID; 21973; -.
DR   KEGG; mmu:21973; -.
DR   UCSC; uc007lid.1; mouse.
DR   AGR; MGI:98790; -.
DR   CTD; 7153; -.
DR   MGI; MGI:98790; Top2a.
DR   VEuPathDB; HostDB:ENSMUSG00000020914; -.
DR   eggNOG; KOG0355; Eukaryota.
DR   GeneTree; ENSGT00940000157539; -.
DR   HOGENOM; CLU_001935_1_0_1; -.
DR   InParanoid; Q01320; -.
DR   OMA; DVKPHMI; -.
DR   OrthoDB; 276498at2759; -.
DR   PhylomeDB; Q01320; -.
DR   BRENDA; 5.99.1.3; 3474.
DR   Reactome; R-MMU-4615885; SUMOylation of DNA replication proteins.
DR   BioGRID-ORCS; 21973; 28 hits in 79 CRISPR screens.
DR   ChiTaRS; Top2a; mouse.
DR   PRO; PR:Q01320; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q01320; protein.
DR   Bgee; ENSMUSG00000020914; Expressed in undifferentiated genital tubercle and 227 other cell types or tissues.
DR   GO; GO:0005814; C:centriole; IEA:Ensembl.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:MGI.
DR   GO; GO:0000793; C:condensed chromosome; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0009330; C:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex; IEA:Ensembl.
DR   GO; GO:0001673; C:male germ cell nucleus; IDA:MGI.
DR   GO; GO:0000228; C:nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0008301; F:DNA binding, bending; ISS:UniProtKB.
DR   GO; GO:0003918; F:DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity; IDA:MGI.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0005080; F:protein kinase C binding; IEA:Ensembl.
DR   GO; GO:0043130; F:ubiquitin binding; IEA:Ensembl.
DR   GO; GO:0030263; P:apoptotic chromosome condensation; IEA:Ensembl.
DR   GO; GO:0006325; P:chromatin organization; IEA:Ensembl.
DR   GO; GO:0030261; P:chromosome condensation; IMP:MGI.
DR   GO; GO:0007059; P:chromosome segregation; IDA:MGI.
DR   GO; GO:0006974; P:DNA damage response; IEA:Ensembl.
DR   GO; GO:0006265; P:DNA topological change; IDA:MGI.
DR   GO; GO:0040016; P:embryonic cleavage; IMP:MGI.
DR   GO; GO:0051309; P:female meiosis chromosome separation; TAS:MGI.
DR   GO; GO:0007143; P:female meiotic nuclear division; IMP:MGI.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; IMP:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0045870; P:positive regulation of single stranded viral RNA replication via double stranded DNA intermediate; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:MGI.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd16930; HATPase_TopII-like; 1.
DR   CDD; cd00187; TOP4c; 1.
DR   CDD; cd03481; TopoIIA_Trans_ScTopoIIA; 1.
DR   CDD; cd03365; TOPRIM_TopoIIA; 1.
DR   FunFam; 1.10.268.10:FF:000002; DNA topoisomerase 2; 1.
DR   FunFam; 3.30.1360.40:FF:000003; DNA topoisomerase 2; 1.
DR   FunFam; 3.30.1490.30:FF:000001; DNA topoisomerase 2; 1.
DR   FunFam; 3.30.230.10:FF:000008; DNA topoisomerase 2; 1.
DR   FunFam; 3.30.565.10:FF:000004; DNA topoisomerase 2; 1.
DR   FunFam; 3.40.50.670:FF:000001; DNA topoisomerase 2; 2.
DR   FunFam; 3.90.199.10:FF:000002; DNA topoisomerase 2; 1.
DR   Gene3D; 3.30.1360.40; -; 1.
DR   Gene3D; 3.30.1490.30; -; 1.
DR   Gene3D; 3.30.230.10; -; 1.
DR   Gene3D; 3.40.50.670; -; 1.
DR   Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1.
DR   Gene3D; 3.90.199.10; Topoisomerase II, domain 5; 1.
DR   Gene3D; 1.10.268.10; Topoisomerase, domain 3; 1.
DR   InterPro; IPR050634; DNA_Topoisomerase_II.
DR   InterPro; IPR012542; DTHCT.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR020568; Ribosomal_Su5_D2-typ_SF.
DR   InterPro; IPR014721; Ribsml_uS5_D2-typ_fold_subgr.
DR   InterPro; IPR001241; Topo_IIA.
DR   InterPro; IPR013760; Topo_IIA-like_dom_sf.
DR   InterPro; IPR013758; Topo_IIA_A/C_ab.
DR   InterPro; IPR013757; Topo_IIA_A_a_sf.
DR   InterPro; IPR013759; Topo_IIA_B_C.
DR   InterPro; IPR013506; Topo_IIA_bsu_dom2.
DR   InterPro; IPR002205; Topo_IIA_dom_A.
DR   InterPro; IPR001154; TopoII_euk.
DR   InterPro; IPR018522; TopoIIA_CS.
DR   InterPro; IPR031660; TOPRIM_C.
DR   InterPro; IPR006171; TOPRIM_dom.
DR   InterPro; IPR034157; TOPRIM_TopoII.
DR   PANTHER; PTHR10169:SF61; DNA TOPOISOMERASE 2-ALPHA; 1.
DR   PANTHER; PTHR10169; DNA TOPOISOMERASE/GYRASE; 1.
DR   Pfam; PF00204; DNA_gyraseB; 1.
DR   Pfam; PF00521; DNA_topoisoIV; 1.
DR   Pfam; PF08070; DTHCT; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   Pfam; PF01751; Toprim; 1.
DR   Pfam; PF16898; TOPRIM_C; 1.
DR   PRINTS; PR01158; TOPISMRASEII.
DR   PRINTS; PR00418; TPI2FAMILY.
DR   SMART; SM00433; TOP2c; 1.
DR   SMART; SM00434; TOP4c; 1.
DR   SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1.
DR   SUPFAM; SSF54211; Ribosomal protein S5 domain 2-like; 1.
DR   SUPFAM; SSF56719; Type II DNA topoisomerase; 1.
DR   PROSITE; PS52040; TOPO_IIA; 1.
DR   PROSITE; PS00177; TOPOISOMERASE_II; 1.
DR   PROSITE; PS50880; TOPRIM; 1.
DR   TreeFam; TF105282; -.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Biological rhythms; Cytoplasm; DNA-binding;
KW   Isomerase; Isopeptide bond; Magnesium; Metal-binding; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome; Topoisomerase;
KW   Ubl conjugation.
FT   CHAIN           1..1528
FT                   /note="DNA topoisomerase 2-alpha"
FT                   /id="PRO_0000145364"
FT   DOMAIN          454..571
FT                   /note="Toprim"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   DOMAIN          714..1168
FT                   /note="Topo IIA-type catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01384"
FT   REGION          341..343
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   REGION          989..998
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   REGION          1090..1118
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1183..1211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1229..1528
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1429..1435
FT                   /note="Interaction with PLSCR1"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   COMPBIAS        1098..1107
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1108..1118
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1258..1270
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1296..1306
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1326..1345
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1506..1519
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        804
FT                   /note="O-(5'-phospho-DNA)-tyrosine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01384"
FT   BINDING         90
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         119
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         147..149
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         160..167
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         375..377
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   BINDING         460
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   BINDING         540
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   BINDING         540
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   BINDING         542
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            488
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            491
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            660
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            661
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            722
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            756
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            762
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   SITE            803
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000250|UniProtKB:P06786"
FT   SITE            855
FT                   /note="Important for DNA bending; intercalates between base
FT                   pairs of target DNA"
FT                   /evidence="ECO:0000250|UniProtKB:P06786"
FT   SITE            930
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00995"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         281
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1105
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1245
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1293
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1323
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1328
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1350
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1373
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1418
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         1438
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         1465
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1472
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   MOD_RES         1521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CROSSLNK        17
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        155
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        156
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        351
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        385
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        396
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        415
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        417
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        424
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        439
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        465
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        479
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        528
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        583
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        598
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        613
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        621
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        624
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        631
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        638
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        654
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        661
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        675
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1074
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1193
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1201
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1226
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1238
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1238
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1272
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1279
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1282
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1359
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1363
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1382
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1418
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1438
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1450
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1455
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1480
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CROSSLNK        1488
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P11388"
FT   CONFLICT        184
FT                   /note="E -> A (in Ref. 1; BAA02076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        260
FT                   /note="S -> M (in Ref. 1; BAA02076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        640
FT                   /note="S -> P (in Ref. 1; BAA02076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        841
FT                   /note="I -> N (in Ref. 1; BAA02076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        844..845
FT                   /note="IP -> NT (in Ref. 1; BAA02076)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1316
FT                   /note="A -> R (in Ref. 1; BAA02076 and 3; AAC52135)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1528 AA;  172790 MW;  63CBF8F649D103C7 CRC64;
     MELSPLQPVN ENMLMNKKKN EDGKKRLSIE RIYQKKTQLE HILLRPDTYI GSVELVTQQM
     WVYDEDVGIN YREVTFVPGL YKIFDEILVN AADNKQRDPK MSCIRVTIDP ENNVISIWNN
     GKGIPVVEHK VEKIYVPALI FGQLLTSSNY DDDEKKVTGG RNGYGAKLCN IFSTKFTVET
     ASREYKKMFK QTWMDNMGRA GDMELKPFSG EDYTCITFQP DLSKFKMQSL DKDIVALMVR
     RAYDIAGSTK DVKVFLNGNS LPVKGFRSYV DLYLKDKVDE TGNSLKVIHE QVNPRWEVCL
     TMSERGFQQI SFVNSIATSK GGRHVDYVAD QIVSKLVDVV KKKNKGGVAV KAHQVKNHMW
     IFVNALIENP TFDSQTKENM TLQAKSFGST CQLSEKFIKA AIGCGIVESI LNWVKFKAQI
     QLNKKCSAVK HTKIKGIPKL DDANDAGSRN STECTLILTE GDSAKTLAVS GLGVVGRDKY
     GVFPLRGKIL NVREASHKQI MENAEINNII KIVGLQYKKN YEDEDSLKTL RYGKIMIMTD
     QDQDGSHIKG LLINFIHHNW PSLLRHRFLE EFITPIVKVS KNKQEIAFYS LPEFEEWKSS
     TPNHKKWKVK YYKGLGTSTS KEAKEYFADM KRHRIQFKYS GPEDDAAISL AFSKKQVDDR
     KEWLTNFMED RRQRKLLGLP EDYLYGQSTS YLTYNDFINK ELILFSNSDN ERSIPSMVDG
     LKPGQRKVLF TCFKRNDKRE VKVAQLAGSV AEMSSYHHGE MSLMMTIINL AQNFVGSNNL
     NLLQPIGQFG TRLHGGKDSA SPRYIFTMLS PLARLLFPPK DDHTLRFLYD DNQRVEPEWY
     IPIIPMVLIN GAEGIGTGWS CKIPNFDVRE VVNNIRRLLD GEEPLPMLPS YKNFKGTIEE
     LASNQYVING EVAILDSTTI EISELPIRTW TQTYKEQVLE PMLNGTEKTP SLITDYREYH
     TDTTVKFVIK MTEEKLAEAE RVGLHKVFKL QSSLTCNSMV LFDHVGCLKK YDTVLDILRD
     FFELRLKYYG LRKEWLLGML GAESSKLNNQ ARFILEKIDG KIVIENKPKK ELIKVLIQRG
     YDSDPVKAWK EAQQKVPDEE ENEESDTETS TSDSAAEAGP TFNYLLDMPL WYLTKEKKDE
     LCKQRNEKEQ ELNTLKQKSP SDLWKEDLAV FIEELEVVEA KEKQDEQVGL PGKAGKAKGK
     KAQMCADVLP SPRGKRVIPQ VTVEMKAEAE KKIRKKIKSE NVEGTPAEDG AEPGSLRQRI
     EKKQKKEPGA KKQTTLPFKP VKKGRKKNPW SDSESDVSSN ESNVDVPPRQ KEQRSAAAKA
     KFTVDLDSDE DFSGLDEKDE DEDFLPLDAT PPKAKIPPKN TKKALKTQGS SMSVVDLESD
     VKDSVPASPG VPAADFPAET EQSKPSKKTV GVKKTATKSQ SSVSTAGTKK RAAPKGTKSD
     SALSARVSEK PAPAKAKNSR KRKPSSSDSS DSDFERAISK GATSKKAKGE EQDFPVDLED
     TIAPRAKSDR ARKPIKYLEE SDDDDDLF
//
